tetano
Editor, Senior Moderator
JACC Heart Fail
. 2021 Jan;9(1):65-73.
doi: 10.1016/j.jchf.2020.11.003.
Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19
Ankeet S Bhatt[SUP] 1 [/SUP], Karola S Jering[SUP] 1 [/SUP], Muthiah Vaduganathan[SUP] 1 [/SUP], Brian L Claggett[SUP] 1 [/SUP], Jonathan W Cunningham[SUP] 1 [/SUP], Ning Rosenthal[SUP] 2 [/SUP], James Signorovitch[SUP] 3 [/SUP], Jens J Thune[SUP] 4 [/SUP], Orly Vardeny[SUP] 5 [/SUP], Scott D Solomon[SUP] 6 [/SUP]
Affiliations
Abstract
Objectives: The purpose of this study was to evaluate in-hospital outcomes among patients with a history of heart failure (HF) hospitalized with coronavirus disease-2019 (COVID-19).
Background: Cardiometabolic comorbidities are common in patients with severe COVID-19. Patients with HF may be particularly susceptible to COVID-19 complications.
Methods: The Premier Healthcare Database was used to identify patients with at least 1 HF hospitalization or 2 HF outpatient visits between January 1, 2019, and March 31, 2020, who were subsequently hospitalized between April and September 2020. Baseline characteristics, health care resource utilization, and mortality rates were compared between those hospitalized with COVID-19 and those hospitalized with other causes. Predictors of in-hospital mortality were identified in HF patients hospitalized with COVID-19 by using multivariate logistic regression.
Results: Among 1,212,153 patients with history of HF, 132,312 patients were hospitalized from April 1, 2020, to September 30, 2020. A total of 23,843 patients (18.0%) were hospitalized with acute HF, 8,383 patients (6.4%) were hospitalized with COVID-19, and 100,068 patients (75.6%) were hospitalized with alternative reasons. Hospitalization with COVID-19 was associated with greater odds of in-hospital mortality as compared with hospitalization with acute HF; 24.2% of patients hospitalized with COVID-19 died in-hospital compared to 2.6% of those hospitalized with acute HF. This association was strongest in April (adjusted odds ratio [OR]: 14.48; 95% confidence interval [CI]:12.25 to 17.12) than in subsequent months (adjusted OR: 10.11; 95% CI: 8.95 to 11.42; p[SUB]interaction[/SUB] <0.001). Among patients with HF hospitalized with COVID-19, male sex (adjusted OR: 1.26; 95% CI: 1.13 to 1.40) and morbid obesity (adjusted OR: 1.25; 95% CI: 1.07 to 1.46) were associated with greater odds of in-hospital mortality, along with age (adjusted OR: 1.35; 95% CI: 1.29 to 1.42 per 10 years) and admission earlier in the pandemic.
Conclusions: Patients with HF hospitalized with COVID-19 are at high risk for complications, with nearly 1 in 4 dying during hospitalization.
Keywords: COVID-19; coronavirus; heart failure.
. 2021 Jan;9(1):65-73.
doi: 10.1016/j.jchf.2020.11.003.
Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19
Ankeet S Bhatt[SUP] 1 [/SUP], Karola S Jering[SUP] 1 [/SUP], Muthiah Vaduganathan[SUP] 1 [/SUP], Brian L Claggett[SUP] 1 [/SUP], Jonathan W Cunningham[SUP] 1 [/SUP], Ning Rosenthal[SUP] 2 [/SUP], James Signorovitch[SUP] 3 [/SUP], Jens J Thune[SUP] 4 [/SUP], Orly Vardeny[SUP] 5 [/SUP], Scott D Solomon[SUP] 6 [/SUP]
Affiliations
- PMID: 33384064
- DOI: 10.1016/j.jchf.2020.11.003
Abstract
Objectives: The purpose of this study was to evaluate in-hospital outcomes among patients with a history of heart failure (HF) hospitalized with coronavirus disease-2019 (COVID-19).
Background: Cardiometabolic comorbidities are common in patients with severe COVID-19. Patients with HF may be particularly susceptible to COVID-19 complications.
Methods: The Premier Healthcare Database was used to identify patients with at least 1 HF hospitalization or 2 HF outpatient visits between January 1, 2019, and March 31, 2020, who were subsequently hospitalized between April and September 2020. Baseline characteristics, health care resource utilization, and mortality rates were compared between those hospitalized with COVID-19 and those hospitalized with other causes. Predictors of in-hospital mortality were identified in HF patients hospitalized with COVID-19 by using multivariate logistic regression.
Results: Among 1,212,153 patients with history of HF, 132,312 patients were hospitalized from April 1, 2020, to September 30, 2020. A total of 23,843 patients (18.0%) were hospitalized with acute HF, 8,383 patients (6.4%) were hospitalized with COVID-19, and 100,068 patients (75.6%) were hospitalized with alternative reasons. Hospitalization with COVID-19 was associated with greater odds of in-hospital mortality as compared with hospitalization with acute HF; 24.2% of patients hospitalized with COVID-19 died in-hospital compared to 2.6% of those hospitalized with acute HF. This association was strongest in April (adjusted odds ratio [OR]: 14.48; 95% confidence interval [CI]:12.25 to 17.12) than in subsequent months (adjusted OR: 10.11; 95% CI: 8.95 to 11.42; p[SUB]interaction[/SUB] <0.001). Among patients with HF hospitalized with COVID-19, male sex (adjusted OR: 1.26; 95% CI: 1.13 to 1.40) and morbid obesity (adjusted OR: 1.25; 95% CI: 1.07 to 1.46) were associated with greater odds of in-hospital mortality, along with age (adjusted OR: 1.35; 95% CI: 1.29 to 1.42 per 10 years) and admission earlier in the pandemic.
Conclusions: Patients with HF hospitalized with COVID-19 are at high risk for complications, with nearly 1 in 4 dying during hospitalization.
Keywords: COVID-19; coronavirus; heart failure.